- Filed
- Feb 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Feb 13, 2024 | 29.16M sh |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $6.32M |
| Cash And Equivalents | Q3 2024 · Mar 31, 2023 | $2.72M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $3.5M |
| Current Liabilities | Q3 2024 · Mar 31, 2023 | $1.3M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $3.61M |
| Total Liabilities | Q3 2024 · Mar 31, 2023 | $1.34M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $6.47M |
| Current Assets | Q3 2024 · Mar 31, 2023 | $3.03M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $6.86M |
| Total Assets | Q3 2024 · Mar 31, 2023 | $3.15M |
| Sga Expense | Q3 2024 · Dec 31, 2023 | $200.27K |
| Sga Expense | Q3 2024 · Dec 31, 2023 | $478.84K |
| Sga Expense | Q3 2024 · Dec 31, 2022 | $76.88K |
| Sga Expense | Q3 2024 · Dec 31, 2022 | $248.32K |
| Capex | Q3 2024 · Dec 31, 2022 | $14.63K |
| Operating Cash Flow | Q3 2024 · Dec 31, 2022 | −$227.52K |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | −$761.67K |
| Stockholders Equity | Q3 2024 · Sep 30, 2022 | −$690.09K |
| Stockholders Equity | Q3 2024 · Mar 31, 2022 | −$673.97K |
| Eps Diluted | Q3 2024 · Dec 31, 2022 | −$0.33 |
| Eps Diluted | Q3 2024 · Dec 31, 2022 | −$1.14 |
| Eps Basic | Q3 2024 · Dec 31, 2022 | −$0.33 |
| Eps Basic | Q3 2024 · Dec 31, 2022 | −$1.14 |
| Net Income | Q3 2024 · Dec 31, 2022 | −$69.07K |
| Net Income | Q3 2024 · Dec 31, 2022 | −$238.5K |
| Operating Income | Q3 2024 · Dec 31, 2022 | −$69.33K |
| Operating Income | Q3 2024 · Dec 31, 2022 | −$240.77K |
| Gross Profit | Q3 2024 · Dec 31, 2022 | $7.55K |
| Gross Profit | Q3 2024 · Dec 31, 2022 | $7.55K |
| Revenue | Q3 2024 · Dec 31, 2022 | $24.06K |
| Revenue | Q3 2024 · Dec 31, 2022 | $47.02K |